HMGB1 affects the progression of neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors through E2F2
Authors:
Open Access
- 24 January 2026
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 26 (1)
Abstract
Malignant peripheral nerve sheath tumors (MPNSTs) represent the most severe complication of neurofibromatosis type 1 (NF1), with limited therapeutic optionKeywords
Funding Information
- National Natural Science Foundation of China (No. 82171364)
This publication has 33 references indexed in Scilit:
- Nuclear HMGB1 is critical for CD8 T cell IFN-γ production and anti-tumor immunityCell Reports, 2024
- Impact of HMGB1 on cancer development and therapeutic insights focused on CNS malignancyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024
- Tumor‐Associated Macrophage‐Derived Exosomal LINC01232 Induces the Immune Escape in Glioma by Decreasing Surface MHC‐I ExpressionAdvanced Science, 2023
- E2F2 enhances the chemoresistance of pancreatic cancer to gemcitabine by regulating the cell cycle and upregulating the expression of RRM2Medical Oncology, 2022
- Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1Brain and Behavior, 2022
- Toll-like Receptors and the Control of ImmunityCell, 2020
- HMGB1-mediated DNA bending: Distinct roles in increasing p53 binding to DNA and the transactivation of p53-responsive gene promotersBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2018
- Cytosolic high-mobility group box protein 1 (HMGB1) and/or PD-1+ TILs in the tumor microenvironment may be contributing prognostic biomarkers for patients with locally advanced rectal cancer who have undergone neoadjuvant chemoradiotherapyCancer Immunology, Immunotherapy, 2017
- Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1The Journal of Pediatrics, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011